Insider Stock Trading History of Kumar Ravindra


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kumar Ravindra since year 2005. The trader's CIK number is 1586835. At the time of this reporting, Kumar Ravindra is the SVP & Chief Scientific Officer of Acceleron Pharma Inc . (stock ticker symbol XLRN). See this page for all insider trading activities at Acceleron Pharma Inc .


Stock purchases, sales, and option exercises reported by insider Kumar Ravindra since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-02 XLRN Acceleron Pharma Inc Sale 4,300 42.41 182,362
2017-09-28 XLRN Acceleron Pharma Inc Option Ex 6,761 5.28 35,698
2017-09-12 XLRN Acceleron Pharma Inc Sale 5,105 38.85 198,329
2017-09-13 XLRN Acceleron Pharma Inc Sale 8 38.12 304
2017-08-08 XLRN Acceleron Pharma Inc Option Ex 13,065 24.11 314,997
2017-08-08 XLRN Acceleron Pharma Inc Sale 13,065 35.41 462,631
2017-07-05 XLRN Acceleron Pharma Inc Option Ex 937 7.12 6,671
2017-07-05 XLRN Acceleron Pharma Inc Sale 937 32.00 29,984
2017-01-04 XLRN Acceleron Pharma Inc Sale 2,000 27.20 54,410
2016-12-22 XLRN Acceleron Pharma Inc Option Ex 14,561 4.58 66,689
2016-10-06 XLRN Acceleron Pharma Inc Sale 16,009 34.65 554,631
2016-10-07 XLRN Acceleron Pharma Inc Option Ex 19,644 9.13 179,428
2016-10-06 XLRN Acceleron Pharma Inc Option Ex 7,124 5.28 37,614
2016-10-10 XLRN Acceleron Pharma Inc Sale 16,833 34.14 574,678
2016-10-10 XLRN Acceleron Pharma Inc Option Ex 16,833 19.73 332,165
2016-10-07 XLRN Acceleron Pharma Inc Sale 19,644 33.69 661,708
2015-10-19 XLRN Acceleron Pharma Inc Option Ex 14,066 4.05 57,009
2015-09-15 XLRN Acceleron Pharma Inc Sale 33,000 35.00 1,155,000
2015-09-15 XLRN Acceleron Pharma Inc Option Ex 11,485 3.88 44,561
2015-03-04 XLRN Acceleron Pharma Inc Option Ex 4,000 5.88 23,520
2015-03-04 XLRN Acceleron Pharma Inc Sale 5,500 41.27 226,957
2015-02-02 XLRN Acceleron Pharma Inc Sale 5,500 38.88 213,867
2015-02-02 XLRN Acceleron Pharma Inc Option Ex 4,000 5.88 23,520
2015-01-12 XLRN Acceleron Pharma Inc Sale 1,500 40.58 60,862
2015-01-02 XLRN Acceleron Pharma Inc Option Ex 4,000 5.88 23,520
2015-01-02 XLRN Acceleron Pharma Inc Sale 4,000 38.87 155,460
2014-12-19 XLRN Acceleron Pharma Inc Option Ex 9,810 1.36 13,341
2014-12-01 XLRN Acceleron Pharma Inc Option Ex 4,000 5.88 23,520
2014-12-01 XLRN Acceleron Pharma Inc Sale 4,000 36.14 144,548
2014-11-13 XLRN Acceleron Pharma Inc Sale 12,000 35.00 420,000
2014-11-12 XLRN Acceleron Pharma Inc Sale 4,000 33.01 132,040
2014-11-12 XLRN Acceleron Pharma Inc Option Ex 4,000 5.88 23,520
2014-11-13 XLRN Acceleron Pharma Inc Option Ex 10,000 5.58 55,800
2014-10-01 XLRN Acceleron Pharma Inc Option Ex 4,000 5.88 23,520
2014-09-30 XLRN Acceleron Pharma Inc Option Ex 5,000 5.58 27,900
2014-09-30 XLRN Acceleron Pharma Inc Sale 7,000 30.00 210,000
2014-10-01 XLRN Acceleron Pharma Inc Sale 4,000 29.96 119,860
2014-09-02 XLRN Acceleron Pharma Inc Sale 2,000 26.40 52,800
2014-09-02 XLRN Acceleron Pharma Inc Option Ex 2,000 5.88 11,760
2014-08-14 XLRN Acceleron Pharma Inc Option Ex 5,000 5.88 29,400
2014-08-14 XLRN Acceleron Pharma Inc Sale 9,000 29.93 269,325
2014-07-01 XLRN Acceleron Pharma Inc Sale 2,000 34.10 68,200
2014-06-20 XLRN Acceleron Pharma Inc Option Ex 5,000 5.88 29,400
2014-06-20 XLRN Acceleron Pharma Inc Sale 7,000 35.00 245,000
2014-06-02 XLRN Acceleron Pharma Inc Sale 2,000 29.72 59,440
2014-05-19 XLRN Acceleron Pharma Inc Option Ex 5,000 5.88 29,400
2014-05-19 XLRN Acceleron Pharma Inc Sale 9,000 31.79 286,065
2014-04-22 XLRN Acceleron Pharma Inc Sale 2,000 35.86 71,720

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kumar Ravindra (SVP & Chief Scientific Officer of Acceleron Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.